Profund Advisors
AXSM icon

Profund Advisors’s Axsome Therapeutics AXSM Stock Holding History

Profund Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.34M Buy
7,291
+6,262
+609% +$1.36M 0.04% 295
2026
Q2 		$252K Sell
1,029
-1,165
-53% -$253K 0.01% 930
2026
Q1 		$371K Sell
2,194
-274
-11% -$47.3K 0.01% 653
2025
Q4 		$451K Sell
2,468
-654
-21% -$91.3K 0.01% 607
2025
Q3 		$379K Sell
3,122
-941
-23% -$106K 0.01% 631
2025
Q2 		$424K Buy
4,063
+180
+5% +$19.1K 0.02% 523
2025
Q1 		$453K Sell
3,883
-1,003
-21% -$114K 0.02% 505
2024
Q4 		$413K Sell
4,886
-730
-13% -$67.1K 0.02% 606
2024
Q3 		$505K Sell
5,616
-1,255
-18% -$110K 0.02% 526
2024
Q2 		$553K Sell
6,871
-2,144
-24% -$159K 0.02% 472
2024
Q1 		$719K Buy
9,015
+701
+8% +$58.8K 0.03% 453
2023
Q4 		$662K Buy
8,314
+181
+2% +$12.1K 0.03% 432
2023
Q3 		$568K Sell
8,133
-711
-8% -$53.2K 0.03% 432
2023
Q2 		$636K Sell
8,844
-1,681
-16% -$124K 0.03% 431
2023
Q1 		$649K Buy
10,525
+7,416
+239% +$487K 0.04% 423
2022
Q4 		$240K Buy
+3,109
New +$186K 0.02% 778
2020
Q3 		– Sell
-2,464
Closed -$203K – 972
2020
Q2 		$203K Buy
+2,464
New +$190K 0.01% 821
2020
Q1 		– Sell
-2,680
Closed -$277K – 812
2019
Q4 		$277K Buy
+2,680
New +$108K 0.01% 974

Other funds holding AXSM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Alethea Capital Management
Alethea Capital Management Mercer Island, Washington $197M AUM 51.86% 1-Year Est. Return

Profund Advisors's AXSM Position: Q3 2026 in Review

Profund Advisors increased its Axsome Therapeutics (AXSM) stake by 609% in Q3 2026, buying an estimated $1.36M and bringing the position to 7,291 shares worth $1.34M. The position accounts for 0.04% of the portfolio, ranked #295.

Profund Advisors first reported a position in AXSM in Q4 2019 and has held it in 18 quarters since. 348 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Profund Advisors held 7,291 shares of Axsome Therapeutics worth $1.34M as of Q3 2026.
  • Profund Advisors bought 6,262 Axsome Therapeutics shares in Q3 2026, an estimated $1.36M.
  • Axsome Therapeutics made up 0.04% of Profund Advisors's portfolio in Q3 2026, its #295 holding.
  • Profund Advisors first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 18 quarters since.
  • 348 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.